C13H8Br2N2OS2, monoclinic, Pc (no. 7), a = 13.4050(4) Å, b = 4.7716(1) Å, c = 11.7303(4) Å, β = 105.885(3)∘$105.885{(3)}^{\circ }$, V = 721.66(4) Å3, Z = 2, Rgt${R}_{gt}$(F) = 0.0294, wRref$w{R}_{ref}$(F2 = 0.0808, T = 160 K
C34H32Br4N4O4, Mr = 880.27, monoclinic, P21/n (no. 14), a = 16.3126(5) Å, b = 6.9654(2) Å, c = 29.30...
C15H17BrO5, monoclinic, P121/n1 (no. 14), a = 11.295(2) Å, b = 23.628(5) Å, c = 16.610(3) Å, β = 92....
In the title molecule, C18H19BrN2O, the benzene ring is inclined to the oxadiazole ring by 10.44 (8)...
C22H29BrN2OS, triclinic, P1̄ (no. 2), a = 7.1722(3) Å, b = 10.2350(4) Å, c = 14.8756(6) Å, α = 73.60...
C18H14Br2S, triclinic, P1̄ (no. 2), a = 7.1658(10) Å, b = 7.6868(11) Å, c = 14.971(2) Å, α = 76.328(...
C10H9BrN2, orthorhombic, P212121 (no. 19), a = 5.9070(3) Å, b = 9.2731(7) Å, c = 17.5641(14) Å, V = ...
C4H2N3BrO4·H2O, monoclinic, P21/c (no. 14), a = 7.177(2) Å, b = 10.999(3) Å, c = 10.414(3) Å, β = 10...
C6H7BrN2O2S, monoclinic, P21/c (no. 14), a = 11.2669(5) Å, b = 8.3859(3) Å, c = 19.4047(8) Å, β = 95...
C14H14BrClN2OS, monoclinic, P21/c (no. 14), a = 9.8377(5) Å, b = 9.6008(5) Å, c = 17.5784(11) Å, ...
C10H6Br2O4S2, monoclinic, P21/c (no. 14), a = 8.1199(6) Å, b = 10.4430(8) Å, c = 15.4252(13) Å, β = ...
C16H16BrNO4S, monoclinic, P21/c (no. 14), a = 9.649(4) Å, b = 15.108(4) Å, c = 14.994(5) Å, β = 128....
C18H19BrN2O5, triclinic, P1̅ (no. 2), a = 9.0429(7) Å, b = 9.5752(11) Å, c = 11.8422(15) Å, α = 7...
C9H14BrNO, monoclinic, C1c1 (no. 9), a = 6.079(1) Å, b = 19.095(4) Å, c = 8.169(1) Å, β = 95.23(1)°,...
C9H8BrF2NO2S, triclinic, P1̅ (no. 2), a = 7.5277(6) Å, b = 8.3730(7) Å, c = 9.8785(9) Å, α = 92.637(...
C6H4BrI, monoclinic, P21/c (no. 14), a = 4.1704(6) Å, b = 5.8242(8) Å, c = 14.929(2) Å, β = 97.315(5...
C34H32Br4N4O4, Mr = 880.27, monoclinic, P21/n (no. 14), a = 16.3126(5) Å, b = 6.9654(2) Å, c = 29.30...
C15H17BrO5, monoclinic, P121/n1 (no. 14), a = 11.295(2) Å, b = 23.628(5) Å, c = 16.610(3) Å, β = 92....
In the title molecule, C18H19BrN2O, the benzene ring is inclined to the oxadiazole ring by 10.44 (8)...
C22H29BrN2OS, triclinic, P1̄ (no. 2), a = 7.1722(3) Å, b = 10.2350(4) Å, c = 14.8756(6) Å, α = 73.60...
C18H14Br2S, triclinic, P1̄ (no. 2), a = 7.1658(10) Å, b = 7.6868(11) Å, c = 14.971(2) Å, α = 76.328(...
C10H9BrN2, orthorhombic, P212121 (no. 19), a = 5.9070(3) Å, b = 9.2731(7) Å, c = 17.5641(14) Å, V = ...
C4H2N3BrO4·H2O, monoclinic, P21/c (no. 14), a = 7.177(2) Å, b = 10.999(3) Å, c = 10.414(3) Å, β = 10...
C6H7BrN2O2S, monoclinic, P21/c (no. 14), a = 11.2669(5) Å, b = 8.3859(3) Å, c = 19.4047(8) Å, β = 95...
C14H14BrClN2OS, monoclinic, P21/c (no. 14), a = 9.8377(5) Å, b = 9.6008(5) Å, c = 17.5784(11) Å, ...
C10H6Br2O4S2, monoclinic, P21/c (no. 14), a = 8.1199(6) Å, b = 10.4430(8) Å, c = 15.4252(13) Å, β = ...
C16H16BrNO4S, monoclinic, P21/c (no. 14), a = 9.649(4) Å, b = 15.108(4) Å, c = 14.994(5) Å, β = 128....
C18H19BrN2O5, triclinic, P1̅ (no. 2), a = 9.0429(7) Å, b = 9.5752(11) Å, c = 11.8422(15) Å, α = 7...
C9H14BrNO, monoclinic, C1c1 (no. 9), a = 6.079(1) Å, b = 19.095(4) Å, c = 8.169(1) Å, β = 95.23(1)°,...
C9H8BrF2NO2S, triclinic, P1̅ (no. 2), a = 7.5277(6) Å, b = 8.3730(7) Å, c = 9.8785(9) Å, α = 92.637(...
C6H4BrI, monoclinic, P21/c (no. 14), a = 4.1704(6) Å, b = 5.8242(8) Å, c = 14.929(2) Å, β = 97.315(5...
C34H32Br4N4O4, Mr = 880.27, monoclinic, P21/n (no. 14), a = 16.3126(5) Å, b = 6.9654(2) Å, c = 29.30...
C15H17BrO5, monoclinic, P121/n1 (no. 14), a = 11.295(2) Å, b = 23.628(5) Å, c = 16.610(3) Å, β = 92....
In the title molecule, C18H19BrN2O, the benzene ring is inclined to the oxadiazole ring by 10.44 (8)...